US 12247004
2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use
granted A61PA61P31/04
Quick answer
US patent 12247004 (2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use) held by Oxford Drug Design Limited expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oxford Drug Design Limited
- Grant date
- Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P31/04